Anthony @ Equity Investigations, Dear Anthony, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: profit_guy who wrote (18986)	3/10/1999 10:08:00 AM
From: QuietWon	Read Replies (2) of 122087

Doing my daily news reads. Also noticed the short on ENMD. What does ENMD have that it commands that type of price when other co's have tested on humans, and are further along in the FDA phases. The only thing that seems to explain it was the co went from 12 to 84 and everyonbe remebers the name and trades it. I'll be happy to see the co's with testing on humans, etc do well and get abobe ENMD's price - just doesn't make sense. Any other reason for such an anomoly? in summary, agree with the short (but haven't) shorted ENMD, based on other co's being further along and BMY pulling out of ENMD research support. Seemed fishy that the next day ENMD announces that thier other technique works.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next